TM3-35243-92493
4 vaccinations
4 coded responses
28 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 770 / TX
- Registered
- 2021-01-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-22
Registered in v-safe
-
2021-01-25
Dose 1 — Moderna
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-01-28
- 2021-01-29
- 2021-01-31
- 2021-02-01
- 2021-02-08
- 2021-02-15
-
2021-02-22
Dose 2 — Moderna
- 2021-02-22
-
2021-02-23
Survey response — days 1–6 daily, dose 2MedDRA: Tremor — Feeling: Fair · Site: Pain, Swelling · Joint pains, Muscle or body aches, Nausea, DiarrheaFree text: A little Shaky.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-24
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: Good · Site: Pain, Swelling · Fatigue or tirednessFree text: Lightheaded a littleMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-25
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
- 2021-02-26
- 2021-02-27
- 2021-02-28
- 2021-03-01
- 2021-03-08
- 2021-03-15
- 2021-03-22
- 2021-03-29
- 2021-04-05
- 2021-05-24
- 2021-08-23
-
2021-09-04
Dose 3 — Moderna
- 2021-12-06
- 2022-03-08
-
2022-04-20
Dose 4 — Pfizer-BioNTech
-
2022-07-20
Survey response — 3 months, dose 4MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: I had covidMedDRA releases: 2024-11 · check-in free text available
-
2022-07-20
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-07-21
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2023-04-20
Survey response — 12 months, dose 4MedDRA: Postmenopausal haemorrhage — Feeling: GoodMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-25 | Moderna | |
| 2 | 2021-02-22 | Moderna | |
| 3 | 2021-09-04 | Moderna | No |
| 4 | 2022-04-20 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): A little Shaky.
Systemic reaction (other): Lightheaded a little
Release 12 — 3 months, dose 4
Symptoms: I had covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Postmenopausal haemorrhage | · | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Tremor | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release